2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
5
Breast Neoplasms
5
Lung Neoplasms
4
Glioblastoma
4
Neoplasms
3
Myelodysplastic Syndromes
3
Squamous Cell Carcinoma of Head and Neck
2
Mycosis Fungoides
2
Mouth Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Gliosarcoma
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thrombosis
1
Radiation Injuries
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Interventions
Geriatric Assessment
12
Standard of Care
3
Preoperative Exercise
3
epigallocatechin gallate
2
Observation
2
Nutritional Support
2
Nutrition Assessment
2
Exercise
2
Ascorbic Acid
2
peflavit
1
microcrystalline cellulose
1
fisetin
1
diacetamate
1
cabozantinib
1
Ultrasonography
1
Tretinoin
1
Therapeutics
1
Temozolomide
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Spectroscopy, Near-Infrared
1
Restraint, Physical
1
Resistance Training
1
Quercetin
1
Qigong
1
Psychosocial Intervention
1
Protons
1
Photons
1
Methods
1
Immunonutrition Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Frailty
×
Photons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled